{"id":550822,"date":"2021-07-01T15:46:02","date_gmt":"2021-07-01T15:46:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=550822"},"modified":"2021-07-01T15:46:02","modified_gmt":"2021-07-01T15:46:02","slug":"sjogrens-syndrome-market-share-trends-epidemiology-forecast-till-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/sjogrens-syndrome-market-share-trends-epidemiology-forecast-till-2030_550822.html","title":{"rendered":"Sjogren\u2019s Syndrome Market, Share, Trends, Epidemiology Forecast Till 2030"},"content":{"rendered":"
\"Sjogren’s<\/a><\/p>\n
\n
DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s \u201cSjogren\u2019s Syndrome Market Insights, Epidemiology, and Market Forecast-2030\u201d report delivers an in-depth understanding of the Sjogren\u2019s Syndrome, historical and forecasted epidemiology as well as the Sjogren\u2019s Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.\n<\/div>\n

Sjogren’s syndrome (SS) is a chronic autoimmune rheumatic disease with specific predisposition for causing inflammation of the exocrine glands, predominantly the salivary and lacrimal glands, including the nose, upper respiratory tract, oropharynx and the vagina in women.<\/p>\n

Some of the key facts of the report:-<\/strong><\/p>\n

* As per DelveInsight estimates, total cases of Sjogren’s syndrome (SS) in the 7MM was found to be 3,270,396 in 2017.<\/p>\n

* Among all the countries, the United States accounts for higher population of Sjogren’s syndrome (SS) with 1,676,238 cases in 2017. <\/p>\n

* Among the EU5 countries, UK had the highest diagnosed prevalent population of Sjögren’s syndrome followed by Germany. On the other hand, Spain had the lowest prevalent population.<\/p>\n

* As per DelveInsight estimates, among the 7MM, Japan had the lowest diagnosed prevalent population of Sjögren’s syndrome in 2017.<\/p>\n

* Females are more prone to SS than males in all countries. In 2017, there were 167,624 prevalent cases of Sjögren’s syndrome in males and 1,508,614 prevalent cases in females.  <\/p>\n

 <\/p>\n

Scope of the Sjogren’s syndrome Market Report<\/a><\/strong><\/p>\n